Rebecca Forman

Rebecca Forman

Auto-generated profile, based on publicly available information

Rebecca Forman

European Observatory on Health Systems and Policies London School of Economics and Political Science London UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Vaccine
Verified
Journal Article
Open access
RKRobin van Kessel
Robin van Kessel
RFRebecca Forman
Rebecca Forman
RMRicarda Milstein
Ricarda Milstein
AMAlicja Mastylak
Alicja Mastylak
Katarzyna CzabanowskaKatarzyna Czabanowska
Katarzyna Czabanowska
EMElias Mossialos
Elias Mossialos
The COVID-19 pandemic highlighted the fragmented nature of governmental policy decisions in Europe. However, the extent to which COVID-19 vaccination policies differed between European countries remains unclear. Here, we mapped the COVID-19 vaccination policies that were in effect in January 2022 as well as booster regulations in April 2022 in Austria, Denmark, England, France, Germany, Ireland, Italy, the Netherlands, Poland, and Spain. National public health and health policy experts from these ten European nations developed and completed an electronic questionnaire. The questionnaire included a series of questions that addressed six critical components of vaccine implementation, including (1) authorization, (2) prioritization, (3) procurement and distribution, (4) data collection, (5) administration, and (6) mandate requirements. Our findings revealed significant variations in COVID-19 vaccination policies across Europe. We observed critical differences in COVID-19 vaccine formulations authorized for use, as well as the specific groups that were provided with priority access. We also identified discrepancies in how vaccination-related data were recorded in each country and what vaccination requirements were implemented. Each of the ten European nations surveyed in this study reported different COVID-19 vaccination policies. These differences complicated efforts to provide a coordinated pandemic response. These findings might alert policymakers in Europe of the need to coordinate their efforts to avoid fostering divergent and socially disruptive policies.

16 November 2021 in Expert Review of Vaccines
Verified
Journal Article
Closed access
KHKobina Hagan
Kobina Hagan
RFRebecca Forman
Rebecca Forman
EMElias Mossialos
Elias Mossialos
PNPaul Ndebele
Paul Ndebele
AHAdnan A Hyder
Adnan A Hyder
KNKhurram Nasir
Khurram Nasir
Vaccination is the most effective strategy to mitigating the COVID-19 pandemic and restoring societal function. As the pandemic evolves with no certainty of a herd immunity threshold, universal vac...

18 October 2022 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
RFRebecca Forman
Rebecca Forman
FAFaiza Ambreen
Faiza Ambreen
SSSyed Shakhar Ahmed Shah
Syed Shakhar Ahmed Shah
EMElias Mossialos
Elias Mossialos
KNKhurram Nasir
Khurram Nasir

27 May 2023 in Health Policy
Verified
Journal Article
Open access
OWOlivier J. Wouters
Olivier J. Wouters
RFRebecca Forman
Rebecca Forman
MAMichael Anderson
Michael Anderson
EMElias Mossialos
Elias Mossialos
MMMartin McKee
Martin McKee
The crowded global health landscape has been joined by the European Union Health Emergency Preparedness and Response Authority (HERA). HERA will assume four broad areas of responsibility: horizon scanning for major health threats; research and development; support for capacity to manufacture drugs, vaccines, and equipment; and procuring and stockpiling key medical countermeasures. In this Health Reform Monitor article, we outline the reform process and describe HERA's structure and responsibilities, explore issues that arise from the creation of this new organisation, and suggest options for collaboration with existing bodies in Europe and beyond. The COVID-19 pandemic and other infectious disease outbreaks have shown the need to treat health as a cross-border issue, and there is now a broad consensus that greater direction and coordination at the European level is needed. This ambition has been matched with a considerable increase in EU funding to tackle cross-border health threats, and HERA can be used to deploy this funding in an effective manner. Yet this is contingent upon clearly defining its role and responsibilities vis-à-vis existing agencies to reduce redundancies.

17 January 2024 in The International Journal of Health Planning and Management
Verified
Journal Article
Closed access
GWGemma A. Williams
Gemma A. Williams
MZMargaret Ziemann
Margaret Ziemann
CCCandice Chen
Candice Chen
RFRebecca Forman
Rebecca Forman
ASAnna Sagan
Anna Sagan
PPPatricia Pittman
Patricia Pittman